Provention Bio, Inc.

    Jurisdiction
    United States
    LEI
    5493003LM26XAVJKLD34
    ISIN
    US74374N1028 (PRVB)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €11.06M
    Gross margin
    96.0%
    EBIT
    -€109.96M
    EBIT margin
    -993.9%
    Net income
    -€96.93M
    Net margin
    -876.1%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Products

    Product Revenue
    Collaboration Revenues €11.71M 105.9%
    Product €1.18M 10.7%

    Earnings Calls

    Latest earnings call: November 3, 2022

    Add to watchlist

    Notifications